Cargando…

Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome

Post-COVID-19 syndrome is a complex of different symptoms, which results in a multisystemic impairment after the suffering from COVID-19 infection. The aim of the study was to reveal the clinical, laboratory, and gut disorders in patients with post-COVID-19 syndrome (n = 39) before and after taking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorokina, Ekaterina, Pautova, Alisa, Fatuev, Oleg, Zakharchenko, Vladislav, Onufrievich, Alexander, Grechko, Andrey, Beloborodova, Natalia, Chernevskaya, Ekaterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302977/ https://www.ncbi.nlm.nih.gov/pubmed/37373960 http://dx.doi.org/10.3390/jpm13060971

Ejemplares similares

4-Hydroxyphenyllactic Acid in Cerebrospinal Fluid as a Possible Marker of Post-Neurosurgical Meningitis: Retrospective Study
por: Pautova, Alisa K., et al.
Publicado: (2022)

Bacteriophage Cocktails in the Post-COVID Rehabilitation
por: Zurabov, Fedor M., et al.
Publicado: (2022)

Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study
por: Chernevskaya, Ekaterina, et al.
Publicado: (2020)

Host-Microbiome Interactions Mediated by Phenolic Metabolites in Chronically Critically Ill Patients
por: Chernevskaya, Ekaterina, et al.
Publicado: (2021)

Gut Microbiota as Early Predictor of Infectious Complications before Cardiac Surgery: A Prospective Pilot Study
por: Chernevskaya, Ekaterina, et al.
Publicado: (2021)

Can procalcitonin reflect the etiology of the bacteremia?
por: Chernevskaya, Ekaterina, et al.
Publicado: (2007)

Multivariate Prognostic Model for Predicting the Outcome of Critically Ill Patients Using the Aromatic Metabolites Detected by Gas Chromatography-Mass Spectrometry
por: Pautova, Alisa K., et al.
Publicado: (2022)

Serum Levels of Mitochondrial and Microbial Metabolites Reflect Mitochondrial Dysfunction in Different Stages of Sepsis
por: Beloborodova, Natalia, et al.
Publicado: (2019)

Determination of Tryptophan Metabolites in Serum and Cerebrospinal Fluid Samples Using Microextraction by Packed Sorbent, Silylation and GC–MS Detection
por: Pautova, Alisa, et al.
Publicado: (2020)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Hi-C Metagenomics in the ICU: Exploring Clinically Relevant Features of Gut Microbiome in Chronically Critically Ill Patients
por: Ivanova, Valeriia, et al.
Publicado: (2022)

Analysis of 4-Hydroxyphenyllactic Acid and Other Diagnostically Important Metabolites of α-Amino Acids in Human Blood Serum Using a Validated and Sensitive Ultra-High-Pressure Liquid Chromatography-Tandem Mass Spectrometry Method
por: Sobolev, Pavel D., et al.
Publicado: (2023)

Microbiota Metabolism Failure as a Risk Factor for Postoperative Complications after Aortic Prosthetics
por: Beloborodova, Natalia, et al.
Publicado: (2023)

Metabolic Profiling and Quantitative Analysis of Cerebrospinal Fluid Using Gas Chromatography–Mass Spectrometry: Current Methods and Future Perspectives
por: Pautova, Alisa, et al.
Publicado: (2021)

Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
por: Chattopadhyay, Indranil, et al.
Publicado: (2022)

Gut microbial dysbiosis correlates with stroke severity markers in aged rats
por: Hammond, Tyler C., et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
por: Pan, Quanren, et al.
Publicado: (2021)

Serum Levels of VEGF-A and Its Receptors in Patients in Different Phases of Hemorrhagic and Ischemic Strokes
por: Babkina, Anastasiya S., et al.
Publicado: (2022)

Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion
por: Fulcher, Jennifer A., et al.
Publicado: (2022)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Gut Dysbiosis and Kidney Diseases
por: Cao, Chujin, et al.
Publicado: (2022)

Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis
por: Huh, Ji-Won, et al.
Publicado: (2020)

The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
por: Magne, Fabien, et al.
Publicado: (2020)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Optimization of antibacterial treatment in pediatric intensive care units using procalcitonin
por: Beloborodova, N, et al.
Publicado: (2007)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Dysbiosis in Patients with Anorexia Nervosa
por: Morita, Chihiro, et al.
Publicado: (2015)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Hyperoxia provokes gut dysbiosis in rats
por: Xing, Zhouxiong, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021)

Epigenetic Regulation of Gut Microbial Dysbiosis
por: Srivastava, Shivani, et al.
Publicado: (2021)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021)

Investigation of Red Blood Cells by Atomic Force Microscopy
por: Sergunova, Viktoria, et al.
Publicado: (2022)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rfb9q1rafl8ggaf1cvav8c0s4h